horn icon

Amneal Launches Beclomethasone MDI

April 2026 — Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) announced the U.S. launch of beclomethasone dipropionate HFA inhalation aerosol…

View Resource

The Latest Market BUZZ

SUBSCRIBE

Name
Subscription Choices
Checkboxes
Subscribe
Receive the latest news, product launches, and insights from RXinsider.
Stay in the Loop

Request information from Amneal Launches Beclomethasone MDI

Name
Address
Subscribe